The field of spinal muscular atrophy (SMA) treatment has been dynamically evolving, and the latest breakthrough stems from Scholar Rock's Phase 3 clinical trial of apitegromab. This experimental drug is designed to preserve muscle function, representing a potential new standard of care for SMA
Merck has unveiled its first GMP-compliant manufacturing line for cell culture media (CCM) in China. This state-of-the-art facility is located at the Life Science Center in Nantong. The endeavor is backed by a substantial €6.6 million ($7.1 million) investment and aims to meet the burgeoning d
Optimizing cell line development (CLD) for next-generation biologics is crucial to meet the rapidly growing demand for novel therapeutic modalities. As the biologics sector evolves, it's imperative to address potential bottlenecks in the development process through strategic enhancements and
The Cell Banking Outsourcing Market is on the brink of a significant upswing, with projections estimating a surge from a robust USD 11.03 billion in 2022 to a staggering USD 33.12 billion by 2029. This exponential growth, driven by an impressive Compound Annual Growth Rate (CAGR) of 17.01%,
The biopharmaceutical industry is on the cusp of a manufacturing evolution, largely due to advancements in analytical technologies. A key player that has emerged in this transformative period is Raman spectroscopy. Renowned for its rapid, nondestructive analysis capabilities, Raman spectroscopy is
The evolution of induced pluripotent stem cell (iPSC) culture is set to be revolutionized with the introduction of AMSBIO's StemFit™ Basic04 CT. This innovative cell culture medium, compliant with Good Manufacturing Practice (GMP) standards, is designed to significantly improve the cultivation
